Dr. James Hu, MD
Claim this profileUSC / Norris Comprehensive Cancer Center
Studies Cancer
Studies Soft Tissue Sarcoma
10 reported clinical trials
18 drugs studied
Area of expertise
1Cancer
Stage IV
EWSR1/ATF1 positive
EWSR1/CREB1 positive
2Soft Tissue Sarcoma
Stage IV
Stage III
EWSR1/ATF1 positive
Affiliated Hospitals
Clinical Trials James Hu, MD is currently running
Atezolizumab +/− Selinexor
for Sarcoma
This trial is testing if atezolizumab alone or with selinexor can shrink tumors in patients with a rare type of cancer called alveolar soft part sarcoma. Atezolizumab boosts the immune system to fight cancer, and selinexor stops cancer cells from growing. The goal is to see if these treatments work better than the usual care.
Recruiting1 award Phase 2
Immunotherapy + Chemotherapy
for Sarcoma
This phase III trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with dedifferentiated liposarcoma (DDLPS), undifferentiated pleomorphic sarcoma (UPS) or a related poorly differentiated sarcoma that has spread from where it first started (primary site) to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Doxorubicin is in a class of medications called anthracyclines. Doxorubicin damages the cell's deoxyribonucleic acid (DNA) and may kill tumor cells. It also blocks a certain enzyme needed for cell division and DNA repair. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding immunotherapy (pembrolizumab) to the standard chemotherapy (doxorubicin) may help patients with metastatic or unresectable DDLPS, UPS or a related poorly differentiated sarcoma live longer without having disease progression.
Recruiting2 awards Phase 310 criteria
More about James Hu, MD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments James Hu, MD has experience with
- Atezolizumab
- Perillyl Alcohol
- TP-1287
- INT230-6
- Bevacizumab
- Carboplatin
Breakdown of trials James Hu, MD has run
Cancer
Soft Tissue Sarcoma
Liposarcoma
Bone Cancer
Alveolar Soft Part Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James Hu, MD specialize in?
James Hu, MD focuses on Cancer and Soft Tissue Sarcoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are EWSR1/ATF1 positive.
Is James Hu, MD currently recruiting for clinical trials?
Yes, James Hu, MD is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that James Hu, MD has studied deeply?
Yes, James Hu, MD has studied treatments such as Atezolizumab, Perillyl alcohol, TP-1287.
What is the best way to schedule an appointment with James Hu, MD?
Apply for one of the trials that James Hu, MD is conducting.
What is the office address of James Hu, MD?
The office of James Hu, MD is located at: USC / Norris Comprehensive Cancer Center, Los Angeles, California 90033 United States. This is the address for their practice at the USC / Norris Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.